Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation

• Main Authors: Sisi Lei (Author), Shuai Zhao (Author), Xiaoyan Huang (Author), Yuchao Feng (Author), Zhishang Li (Author), Li Chen (Author), Peiying Huang (Author), Hansu Guan (Author), Haobo Zhang (Author), Qihua Wu (Author), Bojun Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common metabolic disease and is intertwined with cardiovascular disorders and diabetes. Chaihu Shugan powder (CSP) is a traditional Chinese medicine with a significant therapeutic effect on metabolic diseases, such as NAFLD. However, i...